- A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
-
Novikov SN, Novikov RV, Merezhko YO, Gotovchikova MY, Ilin ND, Melnik YS, Kanaev SV
- KMID: 2533420
- Radiat Oncol J.
- 2022 Sep;40(3):200-207.
- doi: 10.3857/roj.2022.00339
Purpose: To compare biochemical recurrence-free survival (BRFS) and toxicity outcomes of high dose rate brachytherapy (HDRB) and stereotactic body radiotherapy (SBRT) boost after elective nodal irradiation for high/very high-risk prostate... -
- CITED
-
- Close
- SHARE
-
- Close
